Which pharma company seeks permission from DGCI for 'phase 2&3' clinical trials of Oxford vaccine under brand name "Covishield" in India?

1. 

Which pharma company seeks permission from DGCI for 'phase 2&3' clinical trials of Oxford vaccine under brand name "Covishield" in India?
[A]. Indian Immunologicals
[B]. Indian Drugs and Pharmaceuticals Limited
[C]. Serum Institute of India
[D]. Bharat Biotech

Answer: Option C

Explanation:

The Serum Institute of India (SII), which has partnered with British-Swedish pharma company AstraZeneca for manufacturing the University of Oxford vaccine candidate for COVID-19, has sought permission from the Drugs Controller General of India (DCGI) for conducting "phase 2/3 human clinical trials" of the potential vaccine.

Workspace Report
Leave a Comment

Current Affairs :: Current Affairs 2020 : More Exercises

Questions & Answers

Aptitude Chemical Engineering Civil Engineering Computer Science & Engineering Current Affairs Data Interpretation Electrical & Electronics Engineering Electronics & Communication Engineering General Knowledge Logical Reasoning Mechanical Engineering Non Verbal Reasoning Verbal Ability Verbal Reasoning

Interviews

HR Interview

Jobs

Sarkari Jobs

Results

Rojgar ResultSarkari Result

Admission

Admission 2023

Admit Card

Admit Card 2023

Answer Key

Answer Key 2023